Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C62H88N13O14P.Co.HO |
| Molecular Weight | 1346.3551 |
| Optical Activity | UNSPECIFIED |
| Additional Stereochemistry | Yes |
| Defined Stereocenters | 14 / 14 |
| E/Z Centers | 0 |
| Charge | 0 |
| Stereo Comments | Octahedral trans |
SHOW SMILES / InChI
SMILES
[OH-].[Co+3].[H][C@]12[N-]C(=C(C)C3=NC(=CC4=NC(=C(C)C5=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]5CCC(N)=O)[C@@](C)(CC(N)=O)[C@@H]4CCC(N)=O)C(C)(C)[C@@H]3CCC(N)=O)[C@](C)(CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@@H]6[C@@H](CO)O[C@@H]([C@@H]6O)N7C=NC8=C7C=C(C)C(C)=C8)[C@H]2CC(N)=O
InChI
InChIKey=YOZNUFWCRFCGIH-WZHZPDAFSA-K
InChI=1S/C62H90N13O14P.Co.H2O/c1-29-20-39-40(21-30(29)2)75(28-70-39)57-52(84)53(41(27-76)87-57)89-90(85,86)88-31(3)26-69-49(83)18-19-59(8)37(22-46(66)80)56-62(11)61(10,25-48(68)82)36(14-17-45(65)79)51(74-62)33(5)55-60(9,24-47(67)81)34(12-15-43(63)77)38(71-55)23-42-58(6,7)35(13-16-44(64)78)50(72-42)32(4)54(59)73-56;;/h20-21,23,28,31,34-37,41,52-53,56-57,76,84H,12-19,22,24-27H2,1-11H3,(H15,63,64,65,66,67,68,69,71,72,73,74,77,78,79,80,81,82,83,85,86);;1H2/q;+3;/p-3/t31-,34-,35-,36-,37+,41-,52-,53-,56-,57+,59-,60+,61+,62+;;/m1../s1
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-ATC |
B03BA03
Created by
admin on Fri Dec 15 15:22:58 UTC 2023 , Edited by admin on Fri Dec 15 15:22:58 UTC 2023
|
||
|
LOINC |
55883-3
Created by
admin on Fri Dec 15 15:22:58 UTC 2023 , Edited by admin on Fri Dec 15 15:22:58 UTC 2023
|
||
|
DSLD |
3479 (Number of products:24)
Created by
admin on Fri Dec 15 15:22:58 UTC 2023 , Edited by admin on Fri Dec 15 15:22:58 UTC 2023
|
||
|
WHO-VATC |
QB03BA03
Created by
admin on Fri Dec 15 15:22:58 UTC 2023 , Edited by admin on Fri Dec 15 15:22:58 UTC 2023
|
||
|
NCI_THESAURUS |
C26017
Created by
admin on Fri Dec 15 15:22:58 UTC 2023 , Edited by admin on Fri Dec 15 15:22:58 UTC 2023
|
||
|
WHO-ATC |
V03AB33
Created by
admin on Fri Dec 15 15:22:58 UTC 2023 , Edited by admin on Fri Dec 15 15:22:58 UTC 2023
|
||
|
WHO-VATC |
QV03AB33
Created by
admin on Fri Dec 15 15:22:58 UTC 2023 , Edited by admin on Fri Dec 15 15:22:58 UTC 2023
|
||
|
FDA ORPHAN DRUG |
9585
Created by
admin on Fri Dec 15 15:22:58 UTC 2023 , Edited by admin on Fri Dec 15 15:22:58 UTC 2023
|
||
|
NDF-RT |
N0000175429
Created by
admin on Fri Dec 15 15:22:58 UTC 2023 , Edited by admin on Fri Dec 15 15:22:58 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
CYANOKIT (AUTHORIZED: POISONING)
Created by
admin on Fri Dec 15 15:22:58 UTC 2023 , Edited by admin on Fri Dec 15 15:22:58 UTC 2023
|
||
|
LOINC |
55882-5
Created by
admin on Fri Dec 15 15:22:58 UTC 2023 , Edited by admin on Fri Dec 15 15:22:58 UTC 2023
|
||
|
LOINC |
55884-1
Created by
admin on Fri Dec 15 15:22:58 UTC 2023 , Edited by admin on Fri Dec 15 15:22:58 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
10.1
Created by
admin on Fri Dec 15 15:22:58 UTC 2023 , Edited by admin on Fri Dec 15 15:22:58 UTC 2023
|
||
|
LOINC |
2440-6
Created by
admin on Fri Dec 15 15:22:58 UTC 2023 , Edited by admin on Fri Dec 15 15:22:58 UTC 2023
|
||
|
WHO-ATC |
B03BA53
Created by
admin on Fri Dec 15 15:22:58 UTC 2023 , Edited by admin on Fri Dec 15 15:22:58 UTC 2023
|
||
|
LIVERTOX |
488
Created by
admin on Fri Dec 15 15:22:58 UTC 2023 , Edited by admin on Fri Dec 15 15:22:58 UTC 2023
|
||
|
LOINC |
55885-8
Created by
admin on Fri Dec 15 15:22:58 UTC 2023 , Edited by admin on Fri Dec 15 15:22:58 UTC 2023
|
||
|
LOINC |
55881-7
Created by
admin on Fri Dec 15 15:22:58 UTC 2023 , Edited by admin on Fri Dec 15 15:22:58 UTC 2023
|
||
|
FDA ORPHAN DRUG |
177403
Created by
admin on Fri Dec 15 15:22:58 UTC 2023 , Edited by admin on Fri Dec 15 15:22:58 UTC 2023
|
||
|
FDA ORPHAN DRUG |
137600
Created by
admin on Fri Dec 15 15:22:58 UTC 2023 , Edited by admin on Fri Dec 15 15:22:58 UTC 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
3342
Created by
admin on Fri Dec 15 15:22:58 UTC 2023 , Edited by admin on Fri Dec 15 15:22:58 UTC 2023
|
PRIMARY | |||
|
C65868
Created by
admin on Fri Dec 15 15:22:58 UTC 2023 , Edited by admin on Fri Dec 15 15:22:58 UTC 2023
|
PRIMARY | |||
|
5514
Created by
admin on Fri Dec 15 15:22:58 UTC 2023 , Edited by admin on Fri Dec 15 15:22:58 UTC 2023
|
PRIMARY | RxNorm | ||
|
27786
Created by
admin on Fri Dec 15 15:22:58 UTC 2023 , Edited by admin on Fri Dec 15 15:22:58 UTC 2023
|
PRIMARY | |||
|
m6116
Created by
admin on Fri Dec 15 15:22:58 UTC 2023 , Edited by admin on Fri Dec 15 15:22:58 UTC 2023
|
PRIMARY | Merck Index | ||
|
44475014
Created by
admin on Fri Dec 15 15:22:58 UTC 2023 , Edited by admin on Fri Dec 15 15:22:58 UTC 2023
|
PRIMARY | |||
|
D006879
Created by
admin on Fri Dec 15 15:22:58 UTC 2023 , Edited by admin on Fri Dec 15 15:22:58 UTC 2023
|
PRIMARY | |||
|
HYDROXOCOBALAMIN
Created by
admin on Fri Dec 15 15:22:58 UTC 2023 , Edited by admin on Fri Dec 15 15:22:58 UTC 2023
|
PRIMARY | Description: Dark red crystals or a red, crystalline powder; odourless. Solubility: Sparingly soluble in water and ethanol (~750 g/l) TS; practically insoluble in acetone R. Category: Antianaemia drug. Storage: Hydroxocobalamin should be kept in a tightly closed container, protected from light and stored at a temperature between 2? and 8?C.Labelling: The designation on the container should state whether the substance is in the anhydrous or hydrated form. Additional information: In aqueous solution, Hydroxocobalamin exists as hydroxocobamide in equilibrium with the hydrated ionic form. The anhydrous form of Hydroxocobalamin is very hygroscopic. Even in the absence of light, it is gradually degraded on exposure to a humid atmosphere, the decomposition being faster at higher temperatures. | ||
|
4309
Created by
admin on Fri Dec 15 15:22:58 UTC 2023 , Edited by admin on Fri Dec 15 15:22:58 UTC 2023
|
PRIMARY | |||
|
Q40X8H422O
Created by
admin on Fri Dec 15 15:22:58 UTC 2023 , Edited by admin on Fri Dec 15 15:22:58 UTC 2023
|
PRIMARY | |||
|
HYDROXOCOBALAMIN
Created by
admin on Fri Dec 15 15:22:58 UTC 2023 , Edited by admin on Fri Dec 15 15:22:58 UTC 2023
|
PRIMARY | |||
|
SUB08074MIG
Created by
admin on Fri Dec 15 15:22:58 UTC 2023 , Edited by admin on Fri Dec 15 15:22:58 UTC 2023
|
PRIMARY | |||
|
100000091430
Created by
admin on Fri Dec 15 15:22:58 UTC 2023 , Edited by admin on Fri Dec 15 15:22:58 UTC 2023
|
PRIMARY | |||
|
Q40X8H422O
Created by
admin on Fri Dec 15 15:22:58 UTC 2023 , Edited by admin on Fri Dec 15 15:22:58 UTC 2023
|
PRIMARY | |||
|
236-533-2
Created by
admin on Fri Dec 15 15:22:58 UTC 2023 , Edited by admin on Fri Dec 15 15:22:58 UTC 2023
|
PRIMARY | |||
|
DB00200
Created by
admin on Fri Dec 15 15:22:58 UTC 2023 , Edited by admin on Fri Dec 15 15:22:58 UTC 2023
|
PRIMARY | |||
|
13422-51-0
Created by
admin on Fri Dec 15 15:22:58 UTC 2023 , Edited by admin on Fri Dec 15 15:22:58 UTC 2023
|
PRIMARY | |||
|
1043
Created by
admin on Fri Dec 15 15:22:58 UTC 2023 , Edited by admin on Fri Dec 15 15:22:58 UTC 2023
|
PRIMARY | |||
|
CHEMBL2103737
Created by
admin on Fri Dec 15 15:22:58 UTC 2023 , Edited by admin on Fri Dec 15 15:22:58 UTC 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
